Clinical trials

At GenesisCare, we challenge ourselves every day to find new and better ways to treat illness and disease and deliver better outcomes for our patients.

Search for clinical trials by location and speciality

A significant number of patients with heart failure implanted with a Cardiac Resynchronisation Therapy (CRT) device fail to respond to therapy. The cause of this non-response is yet to be determined.    The purpose of this study is to assess the pattern of electrical wiring of the heart, identify the variations seen in individuals with heart failure and their response to CRT. This study will also evaluate the link of CRT response to septal scar (heart scar tissue) and patterns of electrocardiogram (ECG). 

Location: Adelaide, Brisbane, Perth, Melbourne, Mulgrave


30 October, 2019

Aortic Valve Stenosis

PORTICO-NG

To evaluate a new valve, the Portico™ NG Transcatheter Aortic Heart Valve, in patients who have symptomatic, severe aortic stenosis and are determined to be at high or extreme surgical risk 

Location: Adelaide, Brisbane


30 October, 2019

Atrial Fibrillation

OPTION

To evaluate a new implantable device, the Watchman FLX in patients with non-valvular atrial fibrillation who have an increased stroke risk.

29 October, 2019

Cardiovascular Disease

VESALIUS

To evaluate if treatment with additional cholesterol lowering medication reduces the risk of major cardiovascular events in patients at high cardiovascular risk

Location: Adelaide, Brisbane, Perth, Bundaberg


22 August, 2019

Type 2 Diabetes

SURPASS-2

To evaluate and compare two medications as add-on therapy to metformin for the treatment of Type 2 Diabetes

Location: Perth, Bundaberg


22 August, 2019

Cardio-Oncology

SUCCOUR MRI SUB-STUDY

To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy

Location: Melbourne, Mulgrave, Brisbane


22 August, 2019

Heart Failure

HEART-FID

To evaluate a new medication for the treatment of patients in heart failure with a reduced ejection fraction and with iron deficiency.

Location: Brisbane


15 May, 2019

Skin Registry

NDROR

To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions

Location: Newcastle , Perth, Brisbane, Bundaberg


15 May, 2019

Prostate Cancer

IMPPORT

The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.

Location: Melbourne , Frankston


15 May, 2019

Brain Cancer

GBM001

The purpose of this project is to measure the uptake of a new type of Positron Emission Tomography (PET) scan (using Ga68-PSMA) in relapsed glioblastoma. We would also like to examine if standard and new x-ray techniques such as PET can be used to predict the behaviour of the cancer. This will allow us to understand if this type of scan gives a clearer image of the tumour when compared to standard scanning.

Location: Newcastle


15 May, 2019

Early Breast Cancer

POSNOC

To assess whether adjuvant therapy alone is no worse than adjuvant therapy plus axillary treatment, in terms of axillary recurrence within 5 years.

Location: Newcastle , Perth


15 May, 2019

Early Breast Cancer

EXPERT

A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence

Location: Newcastle , Brisbane, Frankston, Melbourne


To evaluate a new valve in patients with severe mitral regurgitation

Location: Adelaide, Brisbane, Melbourne, Perth


15 May, 2019

Heart Failure Device

COAST

To evaluate a new heart failure sensing device in patients with heart failure

Location: Brisbane


24 April, 2019

Pericarditis

RHAPSODY

To evaluate a new medication for the treatment of recurrent pericarditis.

Location: Melbourne, Brisbane


24 April, 2019

Cardiovascular disease and obesity

SELECT

To evaluate if treatment with a new medication reduces the risk of cardiovascular disease in overweight or obese patients

Location: Brisbane, Joondalup

Clinical Trials

At GenesisCare, we challenge ourselves every day to find new and better ways to treat illness and disease and deliver better outcomes for our patients.

Heart Failure and Cardiac Resynchronisation Therapy

SMART

A significant number of patients with heart failure implanted with a Cardiac Resynchronisation Therapy (CRT) device fail to respond to therapy. The cause of this non-response is yet to be determined.    The purpose of this study is to assess the pattern of electrical wiring of the heart, identify the variations seen in individuals with heart failure and their response to CRT. This study will also evaluate the link of CRT response to septal scar (heart scar tissue) and patterns of electrocardiogram (ECG). 

Leabrook

284 Kensington Road, Leabrook, SA 5068

Heart Failure and Cardiac Resynchronisation Therapy

SMART

A significant number of patients with heart failure implanted with a Cardiac Resynchronisation Therapy (CRT) device fail to respond to therapy. The cause of this non-response is yet to be determined.    The purpose of this study is to assess the pattern of electrical wiring of the heart, identify the variations seen in individuals with heart failure and their response to CRT. This study will also evaluate the link of CRT response to septal scar (heart scar tissue) and patterns of electrocardiogram (ECG). 

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Heart Failure and Cardiac Resynchronisation Therapy

SMART

A significant number of patients with heart failure implanted with a Cardiac Resynchronisation Therapy (CRT) device fail to respond to therapy. The cause of this non-response is yet to be determined.    The purpose of this study is to assess the pattern of electrical wiring of the heart, identify the variations seen in individuals with heart failure and their response to CRT. This study will also evaluate the link of CRT response to septal scar (heart scar tissue) and patterns of electrocardiogram (ECG). 

Murdoch (Cardiology)

St John of God Wexford Medical Centre, Level 4, Suite 68-72, 3 Barry Marshall Parade, Murdoch, WA 6150

Heart Failure and Cardiac Resynchronisation Therapy

SMART

A significant number of patients with heart failure implanted with a Cardiac Resynchronisation Therapy (CRT) device fail to respond to therapy. The cause of this non-response is yet to be determined.    The purpose of this study is to assess the pattern of electrical wiring of the heart, identify the variations seen in individuals with heart failure and their response to CRT. This study will also evaluate the link of CRT response to septal scar (heart scar tissue) and patterns of electrocardiogram (ECG). 

Bundoora

Health and Wellness Centre Level 1, Suites 8-10, 20 Scholar Drive, Bundoora, VIC, 3083

Heart Failure and Cardiac Resynchronisation Therapy

SMART

A significant number of patients with heart failure implanted with a Cardiac Resynchronisation Therapy (CRT) device fail to respond to therapy. The cause of this non-response is yet to be determined.    The purpose of this study is to assess the pattern of electrical wiring of the heart, identify the variations seen in individuals with heart failure and their response to CRT. This study will also evaluate the link of CRT response to septal scar (heart scar tissue) and patterns of electrocardiogram (ECG). 

Heidelberg

Suite 1, Warringal Private Hospital, 216 Burgundy Street, Heidelberg VIC 3084

Heart Failure and Cardiac Resynchronisation Therapy

SMART

A significant number of patients with heart failure implanted with a Cardiac Resynchronisation Therapy (CRT) device fail to respond to therapy. The cause of this non-response is yet to be determined.    The purpose of this study is to assess the pattern of electrical wiring of the heart, identify the variations seen in individuals with heart failure and their response to CRT. This study will also evaluate the link of CRT response to septal scar (heart scar tissue) and patterns of electrocardiogram (ECG). 

Mulgrave

Mulgrave Private Hospital, Suite 8, Churchill Consulting Suites, Blanton Drive, Mulgrave, VIC, 3170

Aortic Valve Stenosis

PORTICO-NG

To evaluate a new valve, the Portico™ NG Transcatheter Aortic Heart Valve, in patients who have symptomatic, severe aortic stenosis and are determined to be at high or extreme surgical risk 

Leabrook

284 Kensington Road, Leabrook, SA 5068

Aortic Valve Stenosis

PORTICO-NG

To evaluate a new valve, the Portico™ NG Transcatheter Aortic Heart Valve, in patients who have symptomatic, severe aortic stenosis and are determined to be at high or extreme surgical risk 

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Aortic Valve Stenosis

PORTICO-NG

To evaluate a new valve, the Portico™ NG Transcatheter Aortic Heart Valve, in patients who have symptomatic, severe aortic stenosis and are determined to be at high or extreme surgical risk 

Mater Brisbane

Mater Private Clinic Suite 5.02 & 5.11, Level 5 550 Stanley Street South Brisbane QLD 4101

Atrial Fibrillation

OPTION

To evaluate a new implantable device, the Watchman FLX in patients with non-valvular atrial fibrillation who have an increased stroke risk.

Greenslopes

Ramsay Specialist Centre Suite 212, Level 2 Newdegate Street, Greenslopes, QLD, 4120

Cardiovascular Disease

VESALIUS

To evaluate if treatment with additional cholesterol lowering medication reduces the risk of major cardiovascular events in patients at high cardiovascular risk

Leabrook

284 Kensington Road, Leabrook, SA 5068

Cardiovascular Disease

VESALIUS

To evaluate if treatment with additional cholesterol lowering medication reduces the risk of major cardiovascular events in patients at high cardiovascular risk

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Cardiovascular Disease

VESALIUS

To evaluate if treatment with additional cholesterol lowering medication reduces the risk of major cardiovascular events in patients at high cardiovascular risk

Joondalup – Shenton House (Cardiology)

Level 3, Shenton House, 57 Shenton Avenue, Joondalup, WA 6027

Cardiovascular Disease

VESALIUS

To evaluate if treatment with additional cholesterol lowering medication reduces the risk of major cardiovascular events in patients at high cardiovascular risk

Friendly Society Private Hospital (FSPH) Bundaberg

Floor 1, 19-23 Bingera Street, Bundaberg QLD 4670

Type 2 Diabetes

SURPASS-2

To evaluate and compare two medications as add-on therapy to metformin for the treatment of Type 2 Diabetes

Joondalup – Shenton House (Cardiology)

Level 3, Shenton House, 57 Shenton Avenue, Joondalup, WA 6027

Type 2 Diabetes

SURPASS-2

To evaluate and compare two medications as add-on therapy to metformin for the treatment of Type 2 Diabetes

Murdoch (Cardiology)

St John of God Wexford Medical Centre, Level 4, Suite 68-72, 3 Barry Marshall Parade, Murdoch, WA 6150

Type 2 Diabetes

SURPASS-2

To evaluate and compare two medications as add-on therapy to metformin for the treatment of Type 2 Diabetes

Friendly Society Private Hospital (FSPH) Bundaberg

Floor 1, 19-23 Bingera Street, Bundaberg QLD 4670

Cardio-Oncology

SUCCOUR MRI SUB-STUDY

To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy

Heidelberg

Suite 1, Warringal Private Hospital, 216 Burgundy Street, Heidelberg VIC 3084

Cardio-Oncology

SUCCOUR MRI SUB-STUDY

To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy

Bundoora

Health and Wellness Centre Level 1, Suites 8-10, 20 Scholar Drive, Bundoora, VIC, 3083

Cardio-Oncology

SUCCOUR MRI SUB-STUDY

To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy

Mulgrave

Mulgrave Private Hospital, Suite 8, Churchill Consulting Suites, Blanton Drive, Mulgrave, VIC, 3170

Cardio-Oncology

SUCCOUR MRI SUB-STUDY

To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy

Berwick (Cardiology)

Unit 2 / 11 Gloucester Avenue, Berwick VIC 3806

Cardio-Oncology

SUCCOUR MRI SUB-STUDY

To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Heart Failure

HEART-FID

To evaluate a new medication for the treatment of patients in heart failure with a reduced ejection fraction and with iron deficiency.

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Skin Registry

NDROR

To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions

Newcastle

Lake Macquarie Private Hospital, 36 Pacific Highway, Gateshead, NSW, 2290

Skin Registry

NDROR

To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions

Mater Hospital, Sydney (Oncology)

The Mater Hospital, 25 Rocklands road, North Sydney, NSW

Skin Registry

NDROR

To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions

Wembley

24 Salvado Road, Wembley WA, Australia

Skin Registry

NDROR

To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions

Joondalup – Shenton House (Oncology)

Shenton House, Level 3, 57 Shenton Avenue, Joondalup, WA 6027

Skin Registry

NDROR

To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions

Wesley Medical Centre (Oncology)

The Wesley Medical Centre, 1/40 Chasely St Auchenflower, Brisbane, QLD, 4066

Skin Registry

NDROR

To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions

Bundaberg (Oncology)

Bundaberg, Mater Hospital (Oncology), 313 Bourbong Street, Bundaberg, QLD, 4670

Prostate Cancer

IMPPORT

The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.

Ringwood (Oncology)

Ringwood Private Hospital, 36 Mount Dandenong Road, Ringwood East VIC 3135

Prostate Cancer

IMPPORT

The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.

Frankston

Frankston Private Hospital, 5 Susono Way, Frankston VIC, 3199

Prostate Cancer

IMPPORT

The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.

Epping Medical Centre

Epping Medical Centre, Ground Floor, 230 Cooper Street, Epping, VIC, 3076

Prostate Cancer

IMPPORT

The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.

Footscray

Western Private Hospital, 1 Marion Street, Footscray, VIC 3011

Prostate Cancer

IMPPORT

The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.

St Vincent's Melbourne

St Vincent's Hospital, Basement Level, Building C, 41 Victoria Parade, Fitzroy, VIC, 3065

Brain Cancer

GBM001

The purpose of this project is to measure the uptake of a new type of Positron Emission Tomography (PET) scan (using Ga68-PSMA) in relapsed glioblastoma. We would also like to examine if standard and new x-ray techniques such as PET can be used to predict the behaviour of the cancer. This will allow us to understand if this type of scan gives a clearer image of the tumour when compared to standard scanning.

Newcastle

Lake Macquarie Private Hospital, 36 Pacific Highway, Gateshead, NSW, 2290

Early Breast Cancer

POSNOC

To assess whether adjuvant therapy alone is no worse than adjuvant therapy plus axillary treatment, in terms of axillary recurrence within 5 years.

Newcastle

Lake Macquarie Private Hospital, 36 Pacific Highway, Gateshead, NSW, 2290

Early Breast Cancer

POSNOC

To assess whether adjuvant therapy alone is no worse than adjuvant therapy plus axillary treatment, in terms of axillary recurrence within 5 years.

Fiona Stanley Hospital

Discovery Way Murdoch University, Murdoch WA 6150, Australia

Early Breast Cancer

EXPERT

A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence

Newcastle

Lake Macquarie Private Hospital, 36 Pacific Highway, Gateshead, NSW, 2290

Early Breast Cancer

EXPERT

A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence

Wesley Medical Centre (Oncology)

The Wesley Medical Centre, 1/40 Chasely St Auchenflower, Brisbane, QLD, 4066

Early Breast Cancer

EXPERT

A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence

Frankston

Frankston Private Hospital, 5 Susono Way, Frankston VIC, 3199

Early Breast Cancer

EXPERT

A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence

Ringwood (Oncology)

Ringwood Private Hospital, 36 Mount Dandenong Road, Ringwood East VIC 3135

Heart Failure due to mitral valve regurgitation

HighLife

To evaluate a new valve in patients with severe mitral regurgitation

St Andrew's Medical Centre

St Andrew's Medical Centre Clinic, Level 2. 321 South Terrace, Adelaide, SA 5000

Heart Failure due to mitral valve regurgitation

HighLife

To evaluate a new valve in patients with severe mitral regurgitation

Leabrook

284 Kensington Road, Leabrook, SA 5068

Heart Failure due to mitral valve regurgitation

HighLife

To evaluate a new valve in patients with severe mitral regurgitation

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Heart Failure due to mitral valve regurgitation

HighLife

To evaluate a new valve in patients with severe mitral regurgitation

Doncaster East

Suite 1, 1008 Doncaster Road, Doncaster East VIC 3109

Heart Failure due to mitral valve regurgitation

HighLife

To evaluate a new valve in patients with severe mitral regurgitation

Heidelberg

Suite 1, Warringal Private Hospital, 216 Burgundy Street, Heidelberg VIC 3084

Heart Failure due to mitral valve regurgitation

HighLife

To evaluate a new valve in patients with severe mitral regurgitation

Perth Mount (Cardiology)

Suite 3, 140 Mounts Bay Road, Perth, WA 6000

Heart Failure due to mitral valve regurgitation

HighLife

To evaluate a new valve in patients with severe mitral regurgitation

Murdoch (Cardiology)

St John of God Wexford Medical Centre, Level 4, Suite 68-72, 3 Barry Marshall Parade, Murdoch, WA 6150

Heart Failure Device

COAST

To evaluate a new heart failure sensing device in patients with heart failure

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Pericarditis

RHAPSODY

To evaluate a new medication for the treatment of recurrent pericarditis.

Berwick (Cardiology)

Unit 2 / 11 Gloucester Avenue, Berwick VIC 3806

Pericarditis

RHAPSODY

To evaluate a new medication for the treatment of recurrent pericarditis.

Doncaster East

Suite 1, 1008 Doncaster Road, Doncaster East VIC 3109

Pericarditis

RHAPSODY

To evaluate a new medication for the treatment of recurrent pericarditis.

Mater Brisbane

Mater Private Clinic Suite 5.02 & 5.11, Level 5 550 Stanley Street South Brisbane QLD 4101

Pericarditis

RHAPSODY

To evaluate a new medication for the treatment of recurrent pericarditis.

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Cardiovascular disease and obesity

SELECT

To evaluate if treatment with a new medication reduces the risk of cardiovascular disease in overweight or obese patients

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Cardiovascular disease and obesity

SELECT

To evaluate if treatment with a new medication reduces the risk of cardiovascular disease in overweight or obese patients

Joondalup Health Campus

Suite 103, Specialist Medical Centre West, Grand Blvd & Shenton Ave, Joondalup, WA, 6027